|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 1.440 USD | +0.35% |
|
+5.88% | -13.25% |
| 07-28 | SNDL Shares Fall After Q2 Swings to Adjusted Operating Loss, Revenue Declines | MT |
| 07-28 | Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 4, 2025. | CI |
| Market Cap | 493M 358M 308M 290M 264M 33.95B 496M 3.43B 1.33B 17.35B 1.34B 1.32B 55.21B | P/E 2026 * |
-23.3x | P/E 2027 * | 198x |
|---|---|---|---|---|---|
| Enterprise Value | 493M 358M 308M 290M 264M 33.95B 496M 3.43B 1.33B 17.35B 1.34B 1.32B 55.21B | EV / Sales 2026 * |
0.54x | EV / Sales 2027 * | 0.53x |
| Free-Float |
95.5% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNDL | Delayed | |
Tradegate
| VY4 | Real-time | |
|
CBOE
| SNDL | Real-time | |
|
Canadian Securities Exchange
| SNDL | Delayed | |
|
Boerse Muenchen
| VY4 | Real-time | |
|
Deutsche Boerse AG
| VY4 | Delayed | |
|
Börse Stuttgart
| VY4 | Delayed |
Last Transcript : SNDL Inc.
| 1 day | +0.35% | ||
| 1 week | +5.88% | ||
| Current month | +5.11% | ||
| 1 month | +17.07% | ||
| 3 months | -0.69% | ||
| 6 months | -4.64% | ||
| Current year | -13.25% |
| 1 week | 1.37 |  | 1.46 |
| 1 month | 1.2 | | 1.46 |
| Current year | 1.16 | | 1.82 |
| 1 year | 1.16 | | 2.89 |
| 3 years | 1.15 | | 2.93 |
| 5 years | 1.15 | | 9.6 |
| 10 years | 1.15 | | 132.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary George
CEO | Chief Executive Officer | 48 | 2020-01-29 |
| Director of Finance/CFO | 53 | 2023-06-30 | |
Phil McBride
CTO | Chief Tech/Sci/R&D Officer | 52 | 2024-11-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Turnbull
BRD | Director/Board Member | 71 | 2018-09-30 |
Greg Mills
CHM | Chairman | 63 | 2019-05-31 |
Zachary George
BRD | Director/Board Member | 48 | 2019-11-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/31/26 | Tax | Company | 89,500 | 0.0344% | ||
| 7/31/26 | Buy | Chief Executive Officer | 10,000 | 0.0038% | ||
| 7/31/26 | Tax | Company | -582,700 | 0.2239% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.35% | +5.88% | -39.75% | -26.15% | 357M | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,024B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 663B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 453B | |
| -0.88% | +0.86% | +29.77% | +36.54% | 349B | |
| -10.89% | -14.63% | +9.27% | +26.87% | 295B | |
| -1.38% | -0.72% | -0.79% | +9.50% | 253B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 236B | |
| -2.32% | -0.65% | -15.84% | -56.91% | 206B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 187B | |
| Average | -3.21% | +0.60% | +17.14% | +36.05% | 366.77B | |
| Weighted average by Cap. | -2.42% | -1.04% | +32.69% | +57.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 909M 660M 568M 534M 487M 62.58B 914M 6.33B 2.45B 31.99B 2.48B 2.42B 102B | 925M 671M 577M 543M 495M 63.63B 929M 6.43B 2.49B 32.52B 2.52B 2.47B 103B |
| Net income | -21.59M -15.67M -13.47M -12.67M -11.57M -1.49B -21.7M -150M -58.1M -759M -58.84M -57.56M -2.42B | 2.1M 1.52M 1.31M 1.23M 1.12M 144M 2.11M 14.61M 5.65M 73.85M 5.72M 5.6M 235M |
| Net Debt | - | - |
Employees
2,751
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | US$1.440 | +0.35% | 1,195,675 |
| 26-09-04 | US$1.435 | +1.77% | 827,388 |
| 26-09-03 | US$1.410 | -0.70% | 1,297,667 |
| 26-09-02 | US$1.420 | +4.41% | 965,887 |
| 26-09-01 | US$1.360 | -0.73% | 1,057,702 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.984CAD
Average target price
4.932CAD
Spread / Average Target
+148.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNDL Stock
Select your edition
All financial news and data tailored to specific country editions
